BAJAJ BROKING

Notification
No new Notification messages
Suraksha Diagnostic IPO is Open!
Apply for the Suraksha Diagnostic IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
ganga pharmaceuticals limited stock

Ganga Pharmaceuticals Limited Share Price

15 0.00 (0.00%)
Nov 18 2024 12:00 AM Pharmaceuticals NSE: GANGAPHARM

Ganga Pharmaceuticals Limited Share Price Update

As of the latest trading session, Ganga Pharmaceuticals Limited share price is currently at 15, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 15.00 and 15.00. Over the past year, Ganga Pharmaceuticals Limited has achieved a return of 14.85 %. In the last month alone, the return has been 0.00 %. Read More...

Ganga Pharmaceuticals Limited Performance

Day Range

Low15.00 High15.00
15.00

52 Week Range

Low 14.36 High 28.49
15.00

Ganga Pharmaceuticals Limited Share Price

539680

GANGAPHARM

img img img img
No Data Available

Open Price

15.00

Prev. Close

15.00

Volume (Shares)

8000.00

Total traded value

1.20

Upper Circuit

18.00

Lower Circuit

12.00

Note: The current prices & values are delayed, Login to your account for live updates.

Ganga Pharmaceuticals Limited Fundamentals


(Standalone)

Market Cap (Cr) 7.30
PE Ratio (TTM) 150.00
Book Value / Share 13.29
Beta 1.43
ROE 0.80%
EPS (TTM) 0.10
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.02

Ganga Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1.31
Operating Expense 1.54
Net Profit 0.02
Net Profit Margin (%) 1.52
Earnings Per Share (EPS) 0.05
EBITDA 0.18
Effective Tax Rate (%) 57.14
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 2.74
Operating Expense 2.91
Net Profit 0.05
Net Profit Margin (%) 1.82
Earnings Per Share (EPS) 0.11
EBITDA 0.29
Effective Tax Rate (%) 33.33
Particulars MAR 2023 (Values in Cr)
Revenue 2.59
Operating Expense 2.83
Net Profit 0.04
Net Profit Margin (%) 1.54
Earnings Per Share (EPS) 0.10
EBITDA 0.30
Effective Tax Rate (%) 20.00
Particulars MAR 2022 (Values in Cr)
Revenue 2.49
Operating Expense 2.69
Net Profit 0.04
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 0.09
EBITDA 0.29
Effective Tax Rate (%) 20.00
Particulars MAR 2021 (Values in Cr)
Revenue 2.37
Operating Expense 2.59
Net Profit 0.02
Net Profit Margin (%) 0.84
Earnings Per Share (EPS) 0.05
EBITDA 0.28
Effective Tax Rate (%) 50.00
Particulars MAR 2020 (Values in Cr)
Revenue 3.08
Operating Expense 2.99
Net Profit 0.19
Net Profit Margin (%) 6.16
Earnings Per Share (EPS) 0.46
EBITDA 0.55
Effective Tax Rate (%) 26.92
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.30
ROE % 0.80
ROCE % 3.18
Total Debt to Total Equity 0.25
EBITDA Margin 10.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.42
ROE % 0.74
ROCE % 3.28
Total Debt to Total Equity 0.35
EBITDA Margin 11.58
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.32
ROE % 0.74
ROCE % 3.32
Total Debt to Total Equity 0.34
EBITDA Margin 12.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.23
ROE % 0.37
ROCE % 3.30
Total Debt to Total Equity 0.30
EBITDA Margin 11.81
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.18
ROE % 3.62
ROCE % 7.23
Total Debt to Total Equity 0.32
EBITDA Margin 17.86
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.64
Total Liabilities 8.64
Total Equity 7.05
Share Outstanding 4836500
Price to Book Ratio 0.00
Return on Assets (%) 0.53
Return on Capital (%) 0.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.98
Total Liabilities 7.98
Total Equity 5.45
Share Outstanding 4061500
Price to Book Ratio 0.00
Return on Assets (%) 0.49
Return on Capital (%) 0.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.99
Total Liabilities 7.99
Total Equity 5.41
Share Outstanding 4061500
Price to Book Ratio 0.77
Return on Assets (%) 0.47
Return on Capital (%) 0.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.66
Total Liabilities 7.66
Total Equity 5.37
Share Outstanding 4061500
Price to Book Ratio 0.00
Return on Assets (%) 0.26
Return on Capital (%) 0.29
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.56
Total Liabilities 7.56
Total Equity 5.35
Share Outstanding 4061500
Price to Book Ratio 0.53
Return on Assets (%) 2.49
Return on Capital (%) 2.77
Particulars MAR 2024 (Values in Cr)
Net Income 0.06
Cash from Operations -1.24
Cash from Investing 0.12
Cash from Financing 1.13
Net change in Cash 0.00
Free Cash Flow -1.22
Particulars MAR 2023 (Values in Cr)
Net Income 0.05
Cash from Operations -0.02
Cash from Investing 0.49
Cash from Financing -0.44
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 0.05
Cash from Operations -0.19
Cash from Investing 0.18
Cash from Financing 0.02
Net change in Cash 0.00
Free Cash Flow -0.18
Particulars MAR 2021 (Values in Cr)
Net Income 0.03
Cash from Operations -0.16
Cash from Investing 0.27
Cash from Financing -0.09
Net change in Cash 0.00
Free Cash Flow -0.14
Particulars MAR 2020 (Values in Cr)
Net Income 0.25
Cash from Operations -0.25
Cash from Investing 0.36
Cash from Financing -0.28
Net change in Cash -0.22
Free Cash Flow -0.24
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 57.16 32.85 3.12 438.04 37.54 / 77.70
BLISS GVS PHARMA LTD 161.70 20.24 1.68 1702.73 92.25 / 165.00
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 360.80 125.28 3.65 1061.87 145.00 / 399.60
GLAXOSMITHKLINE PHARMA LT 2445.70 51.67 24.76 41431.63 1639.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 57.16 49.70 9.71 438.04 37.54 / 77.70
AMRUTAJAN HEALTH LTD 739.00 44.95 7.17 2136.50 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6562.10 127.44 24.14 16405.25 4050.15 / 8139.85
BLISS GVS PHARMA LTD 161.70 21.05 1.66 1702.73 92.25 / 165.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
15.00
PIVOT
First Resistance 15.00
Second Resistance 15.00
Third Resistance 15.00
First Support 15.00
Second Support 15.00
Third Support 15.00
RSI 37.47
MACD 0.00
Commodity Channel Index (CCI) -175.54
ADX 28.43
Williams % R -100.00

Over 1 Month

down

0.00

Over 3 Months

down

-23.35

Over 6 Months

down

-39.19

Over 1 Year

down

14.85

Over 3 Years

down

39.71

Over 5 Years

down

20.11

Ganga Pharmaceuticals Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Ganga Pharmaceuticals Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
43.97
Promoter Holdings
56.02
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sharma Bharat B Shareholding of Promoter and Promoter Group 1456585.0 30.12
Lenus Finvest Private Limited Public Shareholding 375000.0 7.75
Brijmohan Sharma Huf Shareholding of Promoter and Promoter Group 349500.0 7.23
Prakash Dhirajlal Tanna Public Shareholding 325000.0 6.72
Anagh Bharat Sharma Shareholding of Promoter and Promoter Group 260000.0 5.38
Srijna Sharma Shareholding of Promoter and Promoter Group 241905.0 5.0
Bharat Brijmohan Sharma Huf Sharma Shareholding of Promoter and Promoter Group 190000.0 3.93
Mr. Niranjan Kumar Goel Public Shareholding 144000.0 2.98
Usha Shukla Shareholding of Promoter and Promoter Group 95110.0 1.97
Amit Shukla Shareholding of Promoter and Promoter Group 76450.0 1.58
Sanjay Dhansukhlal Shah Public Shareholding 72000.0 1.49
Akshay Amarnath Sharma Public Shareholding 72000.0 1.49
Vaibhaviben Nitinkumar Akhani Public Shareholding 50000.0 1.03
Ankita Amit Shukla Shareholding of Promoter and Promoter Group 40000.0 0.83

Ganga Pharmaceuticals Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Ganga Pharmaceuticals Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Ganga Pharmaceuticals Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ganga Pharmaceuticals Ltd?

Answer Field

The share price of Ganga Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 15.00.

What is the Market Cap of Ganga Pharmaceuticals Ltd?

Answer Field

The market cap of Ganga Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 7.30 Cr. as of now.

What is the 52 Week High and Low of Ganga Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Ganga Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 28.49 and ₹ 13.06.

How to Buy Ganga Pharmaceuticals Ltd share?

Answer Field

You can trade in Ganga Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ganga Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 14.85%.

What is the Current Share Price of Ganga Pharmaceuticals Ltd?

Answer Field

Ganga Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 15.00 as on Nov 18 2024 12:00 AM.

What is the Market Cap of Ganga Pharmaceuticals Ltd Share?

Answer Field

The market cap of Ganga Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 7.30 as on Nov 18 2024 12:00 AM.

What is the P/E Ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Nov 18 2024 12:00 AM the price-to-earnings (PE) ratio for Ganga Pharmaceuticals Ltd share is 150.00.

What is the PB ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Nov 18 2024 12:00 AM, the price-to-book (PB) ratio for Ganga Pharmaceuticals Ltd share is 13.29.

How to Buy Ganga Pharmaceuticals Ltd Share?

Answer Field

You can trade in Ganga Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ganga Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Ganga Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ganga Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader